Ilunocitinib |
| Katalog-Nr.GC63309 |
Ilunocitinib (Verbindung 27) ist ein JAK-Inhibitor (aus Patent WO2009114512A1).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1187594-14-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Ilunocitinib (compound 27) is a JAK inhibitor (extracted from patent WO2009114512A1)[1].
[1]. James D. Rodgers, et al. Azetidine and cyclobutane derivatives as jak inhibitors. Patent. WO2009114512A1.
Review for Ilunocitinib
Average Rating: 5 (Based on Reviews and 34 reference(s) in Google Scholar.)
Review for Ilunocitinib
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *